{
  "ticker": "ACR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963731",
  "id": "02963731",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250630",
  "time": "1458",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250630/pdf/06l8g6nslwnlp2.pdf",
  "summary": "**Summary of ASX Announcement (Form 604 - Change in Substantial Holding):**  \n\n- **Holder:** Phillip Asset Management Ltd (BioScience Managers Translation Fund I)  \n- **Change:** Voting power diluted from **10.32% to 9.21%** due to issuance of new shares by Acrux Limited (no change in actual holdings: 37,561,419 ordinary shares remain).  \n- **Dilution Dates:** 23/12/24, 13/02/25, 18/02/25, 03/03/25, 23/05/25 (no further details on share quantities issued).  \n\n**No material capital raising or trading impact identified; indicates ongoing dilution from undisclosed share issuances.**",
  "usage": {
    "prompt_tokens": 1630,
    "completion_tokens": 158,
    "total_tokens": 1788,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-30T05:52:43.078161"
}